Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5532278A · kind A · utility
43Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 1995 |
| Grant date | Jul 2, 1996 |
| Priority date | — |
| Expiry date | Jan 31, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/216
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer. Pharmaceutical compositions comprising (S)-oxybutynin and an acceptable carrier are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.